Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Company profile

Action For M.E.

Action For M.E. is a UK company with status active founded in 1994 based in South West England.

CRN
02906840
Founded
1994
Age
32

Overview

Legal name
ACTION FOR M.E.
Region
South West England
Registered address
UNIT 2.2 STREAMLINE.
436-441 PAINTWORKS
BRISTOL
ENGLAND
BS4 3AS
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

11 events
25 May
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

26 May
2026

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzUyMzI4OTIxMWFkaXF6a2N4

Published 26 May 2026 11:12

11 May
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

31 Oct
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MTY1MjIxNGFkaXF6a2N4

Published 31 Oct 2024 06:23

31 Oct
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MTY1MjE1NGFkaXF6a2N4

Published 31 Oct 2024 06:22

31 Oct
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQ0MTY1MjE0NmFkaXF6a2N4

Published 31 Oct 2024 06:22

08 Oct
2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQzODc1Mzg5N2FkaXF6a2N4

Published 08 Oct 2024 03:49

08 Oct
2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQzODc1MzY4NWFkaXF6a2N4

Published 08 Oct 2024 03:47

10 Mar
1994

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2023
Funded years
2023
Age at first award
29 years

Projects

2023 Collaborative R&D

LOCOME - Long Covid and ME/CFS Diagnosis and Stratification

1 Dec 2023 to 30 Nov 2025

Awarded
£29,470
Total cost £29,470

The LOCOME project will analyze integrated, multi-modal patient datasets to identify and stratify the disease mechanisms underpinning ME/CFS and long COVID. LOCOME will use these novel disease insights to develop diagnostic/prognostic tools that diagnose chronic fatigue patients more accurately and rapidly, and find the most appropriate treatments for spe...

Product types

Collaborative R&D